Amwell (AMWL) has announced CFO Mark Hirschhorn will take on an expanded role as COO, effective Jan. 1, 2025. Hirschhorn will now oversee the company’s operational and growth strategies, including the clinical, sales and marketing teams, while continuing his responsibilities as CFO. Two executives will leave the company. chief commercial and growth officer Kathy Weiler, and COO Kurt Knight, will depart Amwell at the end of the year.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.